SUCAMPO PHARMACEUTICALS INC's ticker is and the CUSIP is 864909AA4. A total of 23 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 19,125,000 | $18,683,000 | 20.40% |
| Mohican Financial Management, LLC | 1,500,000 | $1,464,000 | 2.55% |
| Wellesley Asset Management | 41,221 | $40,448,000 | 2.09% |
| Context Capital Management, LLC | 2,000,000 | $1,961,000 | 1.40% |
| LINDEN ADVISORS LP | 30,205,000 | $29,574,000 | 1.25% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,341,000 | $30,675,000 | 0.46% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,000,000 | $26,388,000,000 | 0.43% |
| AQR Arbitrage LLC | 34,950,000 | $34,295,000 | 0.38% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,196,000 | $24,617,000 | 0.31% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 4,308,000 | $4,220,000 | 0.08% |